IllnessEhlers-Danlos syndromes, differential diagnosis
Summary
Comprehensive differential diagnostic panel for Ehlers-Danlos syndrome cobntaining 5 guideline-curated core genes, 14 additional guideline-curated genes and altogether 55 curated genes according to the clinical signs
155,3 kb (Extended panel: incl. additional genes)
- EDTA-anticoagulated blood (3-5 ml)
NGS +
[Sanger]
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
COL1A1 | 4395 | NM_000088.4 | AD | |
COL1A2 | 4101 | NM_000089.4 | AD, AR | |
COL3A1 | 4401 | NM_000090.4 | AD, AR | |
COL5A1 | 5517 | NM_000093.5 | AD | |
COL5A2 | 4500 | NM_000393.5 | AD | |
TNXB | 12729 | NM_019105.8 | AR | |
ADAMTS2 | 3636 | NM_014244.5 | AR | |
AEBP1 | 3477 | NM_001129.5 | AR | |
ALDH18A1 | 2388 | NM_002860.4 | AD, AR | |
ATP6V0A2 | 2571 | NM_012463.4 | AR | |
ATP7A | 4503 | NM_000052.7 | XLR | |
B3GALT6 | 990 | NM_080605.4 | AR | |
B4GALT7 | 984 | NM_007255.3 | AR | |
BGN | 1107 | NM_001711.6 | XL | |
C1R | 1884 | NM_001733.7 | AD | |
C1S | 2067 | NM_201442.4 | AD | |
CBS | 1656 | NM_000071.3 | AR | |
CHST14 | 1131 | NM_130468.4 | AR | |
COL12A1 | 9192 | NM_004370.6 | AD, AR | |
COL6A1 | 3087 | NM_001848.3 | AD, AR | |
COL6A2 | 3060 | NM_001849.4 | AD, AR | |
COL6A3 | 9534 | NM_004369.4 | AD, AR | |
DSE | 2877 | NM_013352.4 | AR | |
EFEMP2 | 1332 | NM_016938.5 | AR | |
ELN | 2175 | NM_000501.4 | AD | |
FBLN5 | 1347 | NM_006329.4 | AD | |
FBN1 | 8616 | NM_000138.5 | AD | |
FBN2 | 8739 | NM_001999.4 | AD | |
FKBP14 | 636 | NM_017946.4 | AR | |
GORAB | 1185 | NM_152281.3 | AR | |
LOX | 1254 | NM_002317.7 | AD | |
LTBP4 | 4763 | NM_003573.2 | AR | |
PLOD1 | 2184 | NM_000302.4 | AR | |
PRDM5 | 1893 | NM_018699.4 | AR | |
PYCR1 | 960 | NM_006907.4 | AR | |
RIN2 | 2688 | NM_018993.4 | AR | |
ROBO3 | 4161 | NM_022370.4 | AR | |
SKI | 2187 | NM_003036.4 | AD | |
SLC39A13 | 1095 | NM_152264.5 | AR | |
SMAD2 | 1404 | NM_005901.6 | AD | |
SMAD3 | 1278 | NM_005902.4 | AD | |
TGFB2 | 1245 | NM_003238.6 | AD | |
TGFB3 | 1239 | NM_003239.5 | AD | |
TGFBR1 | 1512 | NM_004612.4 | AD | |
TGFBR2 | 1704 | NM_003242.6 | AD | |
ZNF469 | 11862 | NM_001367624.2 | AR |
Informations about the disease
The different types of Ehlers-Danlos syndrome form a heterogeneous group of diseases characterised by fragility of the soft connective tissue and manifest themselves in the skin, ligaments, joints, blood vessels and/or internal organs. The clinical spectrum is very diverse and ranges from mild skin and joint hypermobility to severe physical disability and life-threatening vascular complications. An overlap with osteogenesis imperfecta is observed. Diseases in this group include classic Ehlers-Danlos syndrome (EDS), musculo-contractival EDS, hypermobile EDS, vascular EDS, arthrochalasia EDS, dermatosparax EDS, periodontal EDS, X-linked EDS, brittle corneal syndrome, classic type 1 and type 2 EDS, cardiac valve EDS, spondylodysplastic EDS, myopathic EDS and kyphoscoliotic EDS.
References: https://www.ncbi.nlm.nih.gov/books/NBK1244/
https://www.ncbi.nlm.nih.gov/books/NBK541503/
https://www.ncbi.nlm.nih.gov/books/NBK1462/
https://www.ncbi.nlm.nih.gov/books/NBK1494/
https://www.ncbi.nlm.nih.gov/books/NBK1279/
- Allelic: Aortic valve disease 1 (NOTCH1)
- Allelic: Developmental + epileptic encephalopathy 93 (ATP6V1A)
- Allelic: Leukemia, Philadelphia chromosome-positive, resistant to imatinib (ABL1)
- Allelic: Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 (MYLK)
- Allelic: Mirror movements 1 and/or agenesis of the corpus callosum (DCC)
- Achondrogenesis, type II or hypochondrogenesis (COL2A1)
- Acromicric dysplasia (FBN1)
- Adams-Oliver syndrome 5 (NOTCH1)
- Al-Gazali syndrome (B3GALT6)
- Aortic aneurysm, familial thoracic 10 (LOX)
- Aortic aneurysm, familial thoracic 6 (ACTA2)
- Aortic aneurysm, familial thoracic 7 (MYLK)
- Arthrogryposis, distal, type 3 (PIEZO2)
- Arthrogryposis, distal, type 5 (PIEZO2)
- Arthrogryposis, distal, with impaired proprioception + touch (PIEZO2)
- Avascular necrosis of the femoral head (COL2A1)
- Bethlem myopathy 1 (COL6A1-3)
- Bethlem myopathy 2 (COL12A1)
- Bone mineral density variation QTL, osteoporosis (COL1A1)
- Brittle cornea syndrome 1 (ZNF469)
- Brittle cornea syndrome 2 (PTDM5)
- C1s deficiency (C1S)
- Caffey disease (COL1A1)
- Congenital heart defects + skeletal malformations syndrome (ABL1)
- Contractural arachnodactyly, congenital (FBN2)
- Cutis laxa, AD (ELN)
- Cutis laxa, AD 2 (FBLN5)
- Cutis laxa, AR, type IA (FBLN5)
- Cutis laxa, AR, type IB (EFEMP2)
- Cutis laxa, AR, type IIA (ATP6V0A2)
- Cutis laxa, AR, type IID (ATP6V1A)
- Cutis laxa, AR, type IIE (LTBP1)
- Cutis laxa, AR, type IIIA (ALDH18A1)
- Cutis laxa, autosomal recessive, type IC (LTBP4)
- Cutis laxa, autosomal recessive, type IIB-IIIB (PYCR1)
- Czech dysplasia (COL2A1)
- Ectopia lentis, familial (FBN1)
- Ehlers Danlos syndrome, musculocontractural type 1 (CHST14)
- Ehlers Danlos syndrome, type VI (PLOD1)
- Ehlers-Danlos syndrome due to tenascin X deficiency (TNXB)
- Ehlers-Danlos syndrome, arthrochalasia type, 1 (COL1A1)
- Ehlers-Danlos syndrome, arthrochalasia type, 2 (COL1A2)
- Ehlers-Danlos syndrome, cardiac valvular type (COL1A2)
- Ehlers-Danlos syndrome, classic type, 1 (COL5A1)
- Ehlers-Danlos syndrome, classic type, 2 (COL5A2)
- Ehlers-Danlos syndrome, classic-like, 2 (AEBP1)
- Ehlers-Danlos syndrome, kyphoscoliotic type, 1 (PLOD1)
- Ehlers-Danlos syndrome, kyphoscoliotic type, 2 (FKBP14)
- Ehlers-Danlos syndrome, musculocontractural type 2 (DSE))
- Ehlers-Danlos syndrome, periodontal type, 1 (C1R)
- Ehlers-Danlos syndrome, periodontal type, 2 (C1S)
- Ehlers-Danlos syndrome, spondylodysplastic type, 1 (B4GALT7)
- Ehlers-Danlos syndrome, spondylodysplastic type, 2 (B3GALT6)
- Ehlers-Danlos syndrome, vascular type (COL3A1)
- Epiphyseal dysplasia, multiple, with myopia + deafness (COL2A1)
- Gaze palsy, familial horizontal, with progressive scoliosis, 1 (ROBO3)
- Gaze palsy, familial horizontal, with progressive scoliosis, 2 (DCC)
- Geleophysic dysplasia 2 (FBN1)
- Geroderma osteodysplasticum (GORAB)
- Homocystinuria, B6-responsive and nonresponsive types (CBS)
- Hypermobile Ehlers-Danlos syndrome (includes EDS type III)
- Kniest dysplasia (COL2A1)
- Kyphoscoliotic EDS (includes FKBP14-kEDS, PLOD1-kEDS)
- Legg-Calve-Perthes disease (COL2A1)
- Loeys-Dietz syndrome 1 (TGFBR1)
- Loeys-Dietz syndrome 2 (TGFBR2)
- Loeys-Dietz syndrome 3 (SMAD3)
- Loeys-Dietz syndrome 4 (TGFB2)
- Loeys-Dietz syndrome 5 (TGFB3)
- MASS syndrome (FBN1)
- Macrocephaly, alopecia, cutis laxa, scoliosis (RIN2)
- Macular degeneration, age-related, 3 (FBLN5)
- Macular degeneration, early-onset (FBN2)
- Marden-Walker syndrome (PIEZO2)
- Marfan lipodystrophy syndrome (FBN1)
- Marfan syndrome (FBN1)
- Meester-Loeys syndrome (BGN)
- Menkes disease (ATP7A)
- Moyamoya disease 5 (ACTA2)
- Multisystemic smooth muscle dysfunction syndrome (ACTA2)
- Neuropathy, hereditary, with or without age-related macular degeneration (FBLN5)
- Occipital horn syndrome (ATP7A)
- Osteoarthritis with mild chondrodysplasia (COL2A1)
- Osteogenesis imperfecta, type I-IV (COL1A1)
- Osteogenesis imperfecta, type II-IV (COL1A2)
- Platyspondylic skeletal dysplasia, Torrance type (COL2A1)
- Polymicrogyria with or without vascular-type EDS (COL3A1)
- Shprintzen-Goldberg syndrome (SKI)
- Spastic paraplegia 9A, AD (ALDH18A1)
- Spastic paraplegia 9B, AR (ALDH18A1)
- Spinal muscular atrophy, distal, X-linked 3 (ATP7A)
- Spondylocheirodysplasia, Ehlers-Danlos syndrome-like (SLC39A13)
- Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with/-out fractures (B3GALT6)
- Spondyloepimetaphyseal dysplasia, Strudwick type (COL2A1)
- Spondyloepimetaphyseal dysplasia, X-linked (BGN)
- Spondyloepiphyseal dysplasia congenita (COL2A1)
- Spondyloepiphyseal dysplasia, Stanescu type (COL2A1)
- Spondyloperipheral dysplasia (COL2A1)
- Stickler sydrome, type I, nonsyndromic ocular (COL2A1)
- Stickler syndrome, type I (COL2A1)
- Stiff skin syndrome (FBN1)
- Supravalvar aortic stenosis (ELN)
- Thrombosis, hyperhomocysteinemic (CBS)
- Ullrich congenital muscular dystrophy 1 (COL6A1-3)
- Ullrich congenital muscular dystrophy 2 (COL12A1)
- VISS s.: Vascular aneurysm, immune dysregulation, skeletal anomalies, skin/joint laxity (IPO8)
- Vitreoretinopathy with phalangeal epiphyseal dysplasia (COL2A1)
- Weill-Marchesani syndrome 2, AD (FBN1)
- Wrinkly skin syndrome (ATP6V0A2)
- AD
- AR
- XL
- XLR
- Multiple OMIM-Ps
Bioinformatics and clinical interpretation
Test-Stärken
- DAkkS-akkreditiertes Labor
- EU-Richtlinie für IVD in Umsetzung
- Qualitäts-kontrolliert arbeitendes Personal
- Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
- Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
- eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
- unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
- unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
- unsere umfassenden klinischen Aussagen
Testeinschränkungen
- Gene mit eingeschränkter Abdeckung werden gekennzeichnet
- Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
- es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
- die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
- Gen-Konversionen
- komplexe Inversionen
- Balancierte Translokationen
- Mitochondriale Varianten
- Repeat-Expansionen, sofern nicht anders dokumentiert
- nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
- niedriger Mosaik-Status
- Repeat-Blöcke von Mononukleotiden
- Indels >50bp (Insertionen-Deletionen)
- Deletionen oder Duplikationen einzelner Exons
- Varianten innerhalb von Pseudogenen
- die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde
Laboratory requirement
Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.
Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.
Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.
Die Untersuchung wird auch für Selbstzahler angeboten.